跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retatel Plus 40/10 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retatel Plus 40/10
Approved
STANDARD
Retatel Plus 40/10
Evertogen Life Sciences Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
733d9cc4bbb268f8
Company
Evertogen Life Sciences Limited
Type
Standard
Approval Details
Approval Id
733d9cc4bbb268f8
Drug Approval Philippines Name
Retatel Plus 40/10
Product Name
Retatel Plus 40/10
Registration Number
DRP-12736-09
Brand Name
Retatel Plus 40/10
Generic Name
Telmisartan + Amlodipine (as besilate)
Dosage Form
Tablet
Dosage Strength
40 mg/10 mg
Manufacturer
Evertogen Life Sciences Limited
Importer
Medinova Pharmaceutical Inc.
Distributor
Reta Drug
Issuance Date
27 September 2024
Expiry Date
30 September 2027
Pharmacologic Category
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
733d9cc4bbb268f8
Type
Standard
Back to Philippines FDA Approvals